| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/02/2013 | CN101289694B Nucleic acid for enhancing synthesis of 2-acetyl-1-pyrrole of plant and fungus |
| 01/02/2013 | CN101275944B High flux test chip of single cell traveling wave dielectric spectrum and test method |
| 01/02/2013 | CN101235418B Detection method, special device and appliance set for genetic mutation detector |
| 01/02/2013 | CN101198867B Methods and devices for controlling the impact of short circuit faults on co-planar electrochemical sensors |
| 01/02/2013 | CN101107357B Free reactant use in nucleic acid-templated synthesis |
| 01/01/2013 | US8346486 Determining the quality of biomolecule samples |
| 01/01/2013 | US8346482 Integrated biosensor and simulation system for diagnosis and therapy |
| 01/01/2013 | US8344158 Fluorescent polymethine cyanine dyes |
| 01/01/2013 | US8344125 Modified iRNA agents |
| 01/01/2013 | US8344124 Probe, probe set, probe carrier, and testing method |
| 01/01/2013 | US8344123 System and method for detection of HIV tropism variants |
| 01/01/2013 | US8344118 Preparation and isolation of 5′ capped MRNA |
| 01/01/2013 | US8344117 Method for detecting and quantifying endogenous wheat DNA sequence |
| 01/01/2013 | US8344113 Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer |
| 01/01/2013 | US8344110 Antibodies to thymic stromal lymphopoietin (TSLP) receptor molecules and uses thereof |
| 01/01/2013 | US8344105 Polypeptides having DNA polymerase activity |
| 01/01/2013 | US8343988 Inhibitors of histone deacetylase |
| 01/01/2013 | US8343932 Protease-sensitive site in apolipoprotein A1, therapeutic and diagnostic implications |
| 01/01/2013 | US8343754 Annealing curve analysis in PCR |
| 01/01/2013 | US8343733 Methods and compositions for identifying a cell phenotype |
| 01/01/2013 | US8343732 Method for determining types of cells |
| 01/01/2013 | US8343731 Method for diagnosing acute cardiac ischemia |
| 01/01/2013 | US8343730 Method for determining the course of proteolytic activity |
| 01/01/2013 | US8343729 Luciferin luminescent substrate of marine ostracod crustacean and method for production thereof |
| 01/01/2013 | US8343726 Using passivive diffusion through porous membranes to detect glutamate dehydrogenase in bodily fluids; screening for toxin, biopolymers and parasites in solution |
| 01/01/2013 | US8343725 Method of diagnosing poor survival prognosis colon cancer using miR-10a |
| 01/01/2013 | US8343724 Method for detecting and quantifying endogenous wheat DNA sequence |
| 01/01/2013 | US8343723 Cytolethal distending toxins and detection of Campylobacter bacteria using the same as a target |
| 01/01/2013 | US8343722 Method for the identification of colorectal tumors |
| 01/01/2013 | US8343721 Methods and kits for nucleic acid amplification |
| 01/01/2013 | US8343720 Methods and probes for identifying a nucleotide sequence |
| 01/01/2013 | US8343719 Microrna as biomarker in cancer |
| 01/01/2013 | US8343718 Strain of SARS-associated coronavirus and applications thereof |
| 01/01/2013 | US8343509 Methods and compositions for detection of bacteria and treatment of diseases and disorders |
| 01/01/2013 | US8343506 Chimeric chikungunya virus and uses thereof |
| 01/01/2013 | US8343500 Peptide composition |
| 01/01/2013 | US8343481 Method of preparing lung alveolar epithelial type II cells derived from embryonic stem cells |
| 01/01/2013 | US8343442 Microfluidic device and methods of using same |
| 01/01/2013 | US8343122 Device for monitoring a patient for a urinary tract infection |
| 12/29/2012 | WO2013000100A1 Noninvasive detection of fetal genetic abnormality |
| 12/29/2012 | CA2791118A1 Noninvasive detection of fetal genetic abnormality |
| 12/27/2012 | WO2012178188A2 Molecular diagnostic panel of eosinophilic gastrointestinal disorders |
| 12/27/2012 | WO2012178087A1 Methods and compositions for the treatment and diagnosis of bladder cancer |
| 12/27/2012 | WO2012178079A1 Monitoring protein trafficking using beta-galactosidase reporter fragment complementation |
| 12/27/2012 | WO2012178046A2 Multivariate diagnostic assays and methods for using same |
| 12/27/2012 | WO2012178034A2 Mutations in pancreatic neoplasms |
| 12/27/2012 | WO2012178007A1 COMPOSITIONS AND METHODS OF DIAGNOSING DISEASES AND DISORDERS ASSOCIATED WITH β CELL DEATH |
| 12/27/2012 | WO2012177963A1 Systems, methods and devices for achieving glycemic balance |
| 12/27/2012 | WO2012177945A2 Diagnostic methods for eosinophilic esophagitis |
| 12/27/2012 | WO2012177906A1 Assays and methods for determining activity of a therapeutic agent in a subject |
| 12/27/2012 | WO2012177887A1 Device, system, and method including micro-patterned cell treatment array |
| 12/27/2012 | WO2012177817A2 Systems and methods for identifying a contributor's str genotype based on a dna sample having multiple contributors |
| 12/27/2012 | WO2012177739A2 Reagents and methods for detecting hcv |
| 12/27/2012 | WO2012177658A2 Methods of treating and preventing staphylococcus aureus infections and associated conditions |
| 12/27/2012 | WO2012177527A1 Immobilized transaminases and process for making and using immobilized transaminase |
| 12/27/2012 | WO2012177089A2 Interspecific and intraspecific chlorella strain microsatellite molecular marker |
| 12/27/2012 | WO2012176860A1 Method for screening substances having body-weight-regulating effect |
| 12/27/2012 | WO2012176651A1 Novel anti-tumor agent, and method for screening for novel anti-tumor agent |
| 12/27/2012 | WO2012176125A1 Marker assisted selection of mammalian subjects with desired phenotype |
| 12/27/2012 | WO2012176004A2 Diagnostic methods for detecting clostridium difficile |
| 12/27/2012 | WO2012175765A1 Method for evaluating the virulence of mycobacterium tuberculosis complex strains and use of mycobacterium tuberculosis complex-strain bacillary aggregates in liquid culture for the purposes of said evaluation |
| 12/27/2012 | WO2012175711A1 Method for predicting the responsiveness of a patient affected with an osteosarcoma to a chemotherapy |
| 12/27/2012 | WO2012175702A1 Rimfampicin analogue useful for infection imaging |
| 12/27/2012 | WO2012175671A1 Kit for detecting biofilms |
| 12/27/2012 | WO2012175637A1 Method for detecting the presence of carbapenemase-producing bacteria in a sample |
| 12/27/2012 | WO2012175562A2 Methylation and microrna markers of early-stage non-small cell lung cancer |
| 12/27/2012 | WO2012175552A1 Specific alleles important for ethanol tolerance |
| 12/27/2012 | WO2012175537A1 Method for predicting the clinical response to chemotherapy in a subject with cancer |
| 12/27/2012 | WO2012175532A1 Modified antibiotic peptides having variable systemic release |
| 12/27/2012 | WO2012175481A1 Compositions and methods for treating leukemia |
| 12/27/2012 | WO2012175454A2 In vitro assay method using immunological technique |
| 12/27/2012 | WO2012175183A1 Determination of direct thrombin inhibitors in fluids like serum or urine |
| 12/27/2012 | WO2012175052A1 Sensitizer for reversing or reducing radiotherapy resistance in cases of esophageal carcinoma, screening method and use thereof |
| 12/27/2012 | WO2012175013A1 System and method for diagnosing human body with abnormal state |
| 12/27/2012 | WO2012174978A1 Strain improvement and process optimization in two-step mixed fermentation for production of vitamin c |
| 12/27/2012 | WO2012174723A1 Risk assessment for phenytoin-induced adverse drug reactions |
| 12/27/2012 | WO2012174666A1 Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease |
| 12/27/2012 | WO2012174646A1 Screening for nitrogen fixation |
| 12/27/2012 | WO2012174610A1 Treatment and diagnosis of epigenetic disorders and conditions |
| 12/27/2012 | WO2012174585A1 Novel brachiaria-urochloa endophytes |
| 12/27/2012 | WO2012149484A3 Method of cryopreservation of stem cell-derived retinal pigment epithelial cells on polymeric substrate |
| 12/27/2012 | WO2012143370A3 Electrochemical biosensor based on hollow coils |
| 12/27/2012 | WO2012142246A3 Rapid test for detection of infection and therapeutic response |
| 12/27/2012 | WO2012138789A3 Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors |
| 12/27/2012 | WO2012138745A3 Pharmacogenetic test for anti-resorptive therapy-associated osteonecrosis of the jaw |
| 12/27/2012 | WO2012135817A3 Microrna 130a,b as a tumor suppressor and sensitizing agent for chemotherapy |
| 12/27/2012 | WO2012135815A3 Methods and kits for detecting cell-free pathogen-specific nucleic acids |
| 12/27/2012 | WO2012135814A3 Microrna29a,b,c as a tumor suppressor and sensitizing agent for chemotherapy |
| 12/27/2012 | WO2012135730A3 Method for verifying bioassay samples |
| 12/27/2012 | WO2012135664A3 Methods and compositions to enable multiplex cold-pcr |
| 12/27/2012 | WO2012135663A3 Two-stage microfluidic device for acoustic particle manipulation and methods of separation |
| 12/27/2012 | WO2012135468A3 Genetics of gender discrimination in date palm |
| 12/27/2012 | WO2012131670A3 Methods for lung cancer clasification |
| 12/27/2012 | WO2012129488A3 Gene signatures associated with rejection or recurrence of cancer |
| 12/27/2012 | WO2012129263A3 Isothermal amplification of nucleic acid |
| 12/27/2012 | WO2012129242A3 Isolation of polymerase-nucleic acid complexes and loading onto substrates |
| 12/27/2012 | WO2012129237A3 Therapeutic agent for emphysema and copd |
| 12/27/2012 | WO2012129157A3 System for performing polymerase chain reaction nucleic acid amplification |
| 12/27/2012 | WO2012129115A3 Materials and methods for profiling micrornas |
| 12/27/2012 | WO2012125712A3 Lung tumor classifier for current and former smokers |